Form 4: ASPI Executive Chairman Sells Shares for Tax Obligations
Insider Transaction Report
ASP Isotopes Inc.'s Executive Chairman, Paul Elliot Mann, sold 162,153 shares of common stock on December 1, 2025, to cover tax withholding obligations under a pre-arranged 10b5-1 trading plan.
Summary
- Paul Elliot Mann, Executive Chairman and Director of ASP Isotopes Inc. (ASPI), reported a sale of common stock.
- The transaction involved the disposition of 162,153 shares of ASPI common stock.
- The sale occurred on December 1, 2025, at a weighted average price of $5.753 per share.
- The shares were sold in multiple transactions within a price range of $5.565 to $5.9565.
- The sale was a "sell to cover" transaction, executed pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025.
- The purpose of the sale was to cover tax withholding obligations related to the vesting of restricted stock awards.
- Following this transaction, Paul Elliot Mann beneficially owns 7,759,538 shares of ASPI common stock directly.
Sentiment
Score: 5
Explanation: The filing reports a routine insider stock sale for tax purposes under a pre-arranged 10b5-1 plan, which is generally considered neutral in terms of company sentiment.
Future Outlook
N/A
Industry Context
This Form 4 filing details a routine insider transaction for tax purposes and does not provide information relevant to broader industry trends or competitive analysis.
Stakeholder Impact
- Shareholders: The sale of shares by an executive could be perceived as a slight negative, but given it is a 'sell to cover' for tax obligations under a 10b5-1 plan, the impact is minimal and generally not indicative of a lack of confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 2025-06-09 | Date Rule 10b5-1 trading plan was adopted by Paul Elliot Mann. |
| 2025-12-01 | Date of transaction (sale of common stock). |
| 2025-12-03 | Date Form 4 was signed and filed. |
Recommendation
holdThe filing details a routine 'sell to cover' transaction by an executive to satisfy tax obligations related to restricted stock vesting, executed under a pre-arranged 10b5-1 plan. This type of insider sale is not typically indicative of a change in the company's fundamentals or management's confidence, and therefore does not warrant a change in investment recommendation based solely on this filing. A 'hold' recommendation is appropriate as this event is neutral.
Keywords
ASP Isotopes Inc., ASPI, Paul Elliot Mann, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, Executive Chairman, Restricted Stock Awards, Tax Obligations
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.